2 insiders reported 4 Form 4 transactions for Liminatus Pharma, Inc. (LIMN) over the past 18 months (most recent 2026-07-14). Recent activity: Kim Chris (Chief Executive Officer) Buy 3.4M shares, Valetudo Therapeutics LLC (10% Owner) Buy 3.4M shares, Kim Chris (Chief Executive Officer) Sell 4.4M shares, Valetudo Therapeutics LLC (10% Owner) Sell 4.4M shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-14 | Kim Chris | Chief Executive Officer | Buy | 3.4M | $0 |
| 2026-07-14 | Valetudo Therapeutics LLC | 10% Owner | Buy | 3.4M | $0 |
| 2026-07-06 | Kim Chris | Chief Executive Officer | Sell | 4.4M | $0 |
| 2026-07-06 | Valetudo Therapeutics LLC | 10% Owner | Sell | 4.4M | $0 |
Source: SEC Form 4 filings · as of 2026-07-14